{"id": "8_U-eiEAAAAJ", "citedby": 2995, "citedby5y": 2542, "hindex": 27, "hindex5y": 23, "i10index": 35, "i10index5y": 34, "coauthors": [], "name": "Cigall Kadoch", "affiliation": "Dana-Farber Cancer Institute, Harvard Medical School, Broad Institute of MIT and Harvard", "interests": ["Chromatin regulation", "ATP-dependent chromatin remodeling", "protein complex structure and function", "biochemistry", "cancer biology"], "cites_per_year": {"2008": 22, "2009": 40, "2010": 48, "2011": 34, "2012": 46, "2013": 80, "2014": 139, "2015": 201, "2016": 257, "2017": 415, "2018": 478, "2019": 771, "2020": 412}, "publications": [{"bib": {"title": "Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy", "year": "2013"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:8k81kl-MbHgC", "citedby": "672"}, {"bib": {"title": "Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics", "year": "2015"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:KlAtU1dfN6UC", "citedby": "333"}, {"bib": {"title": "Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma", "year": "2013"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:5nxA0vEk-isC", "citedby": "257"}, {"bib": {"title": "CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma", "year": "2013"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:W7OEmFMy1HYC", "citedby": "134"}, {"bib": {"title": "Protein biomarker identification in the CSF of patients with CNS lymphoma", "year": "2008"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:u5HHmVD_uO8C", "citedby": "134"}, {"bib": {"title": "Dynamics of BAF\u2013Polycomb complex opposition on heterochromatin in normal and oncogenic states", "year": "2017"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:hFOr9nPyWt4C", "citedby": "111"}, {"bib": {"title": "Method and apparatus for testing and charging a power source", "year": "2006"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:f2IySw72cVMC", "citedby": "102"}, {"bib": {"title": "Cancer-specific retargeting of BAF complexes by a prion-like domain", "year": "2017"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:maZDTaKrznsC", "citedby": "93"}, {"bib": {"title": "Smarca4 ATPase mutations disrupt direct eviction of PRC1 from chromatin", "year": "2017"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:mB3voiENLucC", "citedby": "86"}, {"bib": {"title": "Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma", "year": "2013"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:qjMakFHDy7sC", "citedby": "86"}, {"bib": {"title": "SMARCB1 is required for widespread BAF complex\u2013mediated activation of enhancers and bivalent promoters", "year": "2017"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:JV2RwH3_ST0C", "citedby": "83"}, {"bib": {"title": "Modular organization and assembly of SWI/SNF family chromatin remodeling complexes", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:70eg2SAEIzsC", "citedby": "77"}, {"bib": {"title": "Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities", "year": "2017"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:4JMBOYKVnBMC", "citedby": "67"}, {"bib": {"title": "PRC2 and SWI/SNF chromatin remodeling complexes in health and disease", "year": "2016"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:mVmsd5A6BfQC", "citedby": "65"}, {"bib": {"title": "Molecular pathogenesis of primary central nervous system lymphoma", "year": "2006"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:EUQCXRtRnyEC", "citedby": "54"}, {"bib": {"title": "A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:M05iB0D1s5AC", "citedby": "53"}, {"bib": {"title": "The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:J_g5lzvAfSwC", "citedby": "51"}, {"bib": {"title": "Pathology of primary central nervous system lymphoma", "year": "2006"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:3fE2CSJIrl8C", "citedby": "50"}, {"bib": {"title": "Interrogation of mammalian protein complex structure, function, and membership using genome-scale fitness screens", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:NaGl4SEjCO4C", "citedby": "42"}, {"bib": {"title": "Targeting CDK9 reactivates epigenetically silenced genes in cancer", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:2P1L_qKh6hAC", "citedby": "41"}, {"bib": {"title": "Biology and treatment of primary central nervous system lymphoma", "year": "2009"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:u-x6o8ySG0sC", "citedby": "37"}, {"bib": {"title": "A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-\u03b2 superfamily", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:lSLTfruPkqcC", "citedby": "36"}, {"bib": {"title": "TOP2 synergizes with BAF chromatin remodeling for both resolution and formation of facultative heterochromatin", "year": "2017"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:e5wmG9Sq2KIC", "citedby": "35"}, {"bib": {"title": "Composition and function of mammalian SWI/SNF chromatin remodeling complexes in human disease", "year": "2016"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:j3f4tGmQtD8C", "citedby": "34"}, {"bib": {"title": "Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model", "year": "2009"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:d1gkVwhDpl0C", "citedby": "31"}, {"bib": {"title": "Differential gene expression in central nervous system lymphoma", "year": "2009"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:9yKSN-GCB0IC", "citedby": "29"}, {"bib": {"title": "Complement activation and intraventricular rituximab distribution in recurrent central nervous system lymphoma", "year": "2014"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:kNdYIx-mwKoC", "citedby": "28"}, {"bib": {"title": "Polycomb and trithorax opposition in development and disease", "year": "2016"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:hC7cP41nSMkC", "citedby": "27"}, {"bib": {"title": "Spliceosomal disruption of the non-canonical BAF complex in cancer", "year": "2019"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:KxtntwgDAa4C", "citedby": "19"}, {"bib": {"title": "Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop", "year": "2016"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:9ZlFYXVOiuMC", "citedby": "19"}, {"bib": {"title": "Chromatin regulatory mechanisms and therapeutic opportunities in cancer", "year": "2019"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:cFHS6HbyZ2cC", "citedby": "17"}, {"bib": {"title": "Binding of TMPRSS2-ERG to BAF chromatin remodeling complexes mediates prostate oncogenesis", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:RYcK_YlVTxYC", "citedby": "13"}, {"bib": {"title": "Disruption of mammalian SWI/SNF and polycomb complexes in human sarcomas: mechanisms and therapeutic opportunities", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:BqipwSGYUEgC", "citedby": "12"}, {"bib": {"title": "The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity\u2013independent genomic targeting", "year": "2019"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:b0M2c_1WBrUC", "citedby": "11"}, {"bib": {"title": "Wiskott\u2013Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma", "year": "2019"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:rO6llkc54NcC", "citedby": "11"}, {"bib": {"title": "Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition", "year": "2019"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:3s1wT3WcHBgC", "citedby": "6"}, {"bib": {"title": "ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer", "year": "2020"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:u9iWguZQMMsC", "citedby": "4"}, {"bib": {"title": "Recurrent SMARCB1 Mutations Reveal a Nucleosome Acidic Patch Interaction Site That Potentiates mSWI/SNF Complex Chromatin Remodeling", "year": "2019"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:OU6Ihb5iCvQC", "citedby": "4"}, {"bib": {"title": "When prostate brachytherapy fails; a case report and discussion", "year": "2005"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:2osOgNQ5qMEC", "citedby": "4"}, {"bib": {"title": "Methods of Inducibly Targeting Chromatin Effectors and Compositions for Use in the Same", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:ldfaerwXgEUC", "citedby": "3"}, {"bib": {"title": "A two-faced mSWI/SNF subunit: dual roles for ARID1A in tumor suppression and Oncogenicity in the liver", "year": "2017"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:hMod-77fHWUC", "citedby": "3"}, {"bib": {"title": "A SMARCD2-containing mSWI/SNF complex is required for granulopoiesis", "year": "2017"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:r0BpntZqJG4C", "citedby": "3"}, {"bib": {"title": "Lifting Up the HAT: Synthetic Lethal Screening Reveals a Novel Vulnerability at the CBP\u2013p300 Axis", "year": "2016"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:QIV2ME_5wuYC", "citedby": "3"}, {"bib": {"title": "Alcohol as a potential contributing factor in radiation complications", "year": "2009"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:hqOjcs7Dif8C", "citedby": "3"}, {"bib": {"title": "Reply to H. Zetterberg et al", "year": "2009"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:LkGwnXOMwfcC", "citedby": "2"}, {"bib": {"title": "Treatment of Primary CNS Lymphoma with Induction High-Dose Methotrexate, Temozolomide, Rituximab Followed by Consolidation Cytarabine/Etoposide: A Pilot Study with Biomarker \u2026", "year": "2007"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:IjCSPb-OGe4C", "citedby": "2"}, {"bib": {"title": "Synthetic lethal and resistance interactions with BET bromodomain inhibitors in triple-negative breast cancer", "year": "2020"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:08ZZubdj9fEC", "citedby": "1"}, {"bib": {"title": "Genomic and immunologic characterization of INI1-deficient pediatric cancers", "year": "2020"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:WbkHhVStYXYC", "citedby": "1"}, {"bib": {"title": "Diverse compositions and functions of chromatin remodeling machines in cancer", "year": "2019"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:1sJd4Hv_s6UC", "citedby": "1"}, {"bib": {"title": "SSX-mediated chromatin engagement and targeting of BAF complexes activates oncogenic transcription in synovial sarcoma.", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:GnPB-g6toBAC", "citedby": "1"}, {"bib": {"title": "SSX drives gain-of-function BAF complex chromatin affinity and genomic targeting in synovial sarcoma", "year": "2017"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:bEWYMUwI8FkC", "citedby": "1"}, {"bib": {"title": "Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma", "year": "2016"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:ULOm3_A8WrAC", "citedby": "1"}, {"bib": {"title": "Novel intracranial xenografts of CNS lymphoma implicate a role for cereblon as a mediator of lenalidomide efficacy", "year": "2013"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:qxL8FJ1GzNcC", "citedby": "1"}, {"bib": {"title": "Complement Activation and Resistance within the Cerebrospinal Fluid Following Intraventricular Administration of Anti-CD20 in the Treatment of Recurrent CNS Lymphoma.", "year": "2007"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:UeHWp8X0CEIC", "citedby": "1"}, {"bib": {"title": "A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma.", "year": "2020"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:738O_yMBCRsC", "citedby": "0"}, {"bib": {"title": "Mammalian SWI/SNF complex genomic alterations and immune checkpoint blockade in solid tumors", "year": "2020"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:tOudhMTPpwUC", "citedby": "0"}, {"bib": {"title": "Arid1a loss potentiates pancreatic \u03b2-cell regeneration through activation of EGF signaling", "year": "2020"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:Tiz5es2fbqcC", "citedby": "0"}, {"bib": {"title": "Spliceosomal Disruption of the Non-Canonical SWI/SNF Chromatin Remodeling Complex in SF3B1 Mutant Leukemias", "year": "2019"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:SP6oXDckpogC", "citedby": "0"}, {"bib": {"title": "Structure and Function of ATP-Dependent Chromatin Remodeling Complexes in Human Cancer", "year": "2019"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:UxriW0iASnsC", "citedby": "0"}, {"bib": {"title": "Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma", "year": "2019"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:nb7KW1ujOQ8C", "citedby": "0"}, {"bib": {"title": "First Rounders: Cigall Kadoch", "year": "2019"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:XiSMed-E-HIC", "citedby": "0"}, {"bib": {"title": "Application of high-density tiling CRISPR screen technology to identify chromatin remodeler complex targets for drug discovery", "year": "2019"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:CHSYGLWDkRkC", "citedby": "0"}, {"bib": {"title": "Bioinformatic method to define epigenetically regulated enhancer elements associated with cancer", "year": "2019"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:xtRiw3GOFMkC", "citedby": "0"}, {"bib": {"title": "ARID1A is a critical regulator of luminal identity and therapeutic response in estrogen receptor-positive breast cancer", "year": "2019"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:NhqRSupF_l8C", "citedby": "0"}, {"bib": {"title": "Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Human Disease", "year": "2019"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:abG-DnoFyZgC", "citedby": "0"}, {"bib": {"title": "Opposing immune and genetic forces shape oncogenic programs in synovial sarcoma", "year": "2019"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:P5F9QuxV20EC", "citedby": "0"}, {"bib": {"title": "Genome-wide mistargeting of oncogenic SWI/SNF complexes in SMARCB1-deficient cancers", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:D03iK_w7-QYC", "citedby": "0"}, {"bib": {"title": "Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NFkB Activation in Preclinical Patient-Derived Models of CNS Lymphoma", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:SeFeTyx0c_EC", "citedby": "0"}, {"bib": {"title": "Methods of identifying compounds that interfere with erg-driven misguidance of baf complexes in tmprss2-erg driven prostate cancers", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:ZHo1McVdvXMC", "citedby": "0"}, {"bib": {"title": "Compounds and methods for treating synovial sarcomas", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:HoB7MX3m0LUC", "citedby": "0"}, {"bib": {"title": "Methods for treating synovial sarcoma", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:g5m5HwL7SMYC", "citedby": "0"}, {"bib": {"title": "Abstract B18: Modeling renal medullary carcinomas identifies druggable vulnerabilities in SMARCB1-deficient cancers", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:35N4QoGY0k4C", "citedby": "0"}, {"bib": {"title": "Abstract PR09: Cancer-specific retargeting of BAF complexes by a prion-like domain", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:vV6vV6tmYwMC", "citedby": "0"}, {"bib": {"title": "Abstract PR11: SSX-mediated chromatin engagement and targeting of BAF complexes activates oncogenic transcription in synovial sarcoma", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:YFjsv_pBGBYC", "citedby": "0"}, {"bib": {"title": "Proteomic analysis of oncogenic SWI/SNF (BAF) complex in SMARCB1 (BAF47)-deficient malignancies", "year": "2018"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:ns9cj8rnVeAC", "citedby": "0"}, {"bib": {"title": "Abstract PR15: BRD9 defines a novel mammalian SWI/SNF (BAF) complex configuration which supports proliferation in AML", "year": "2017"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:NMxIlDl6LWMC", "citedby": "0"}, {"bib": {"title": "Biochemical Analysis of SMARCB1 (BAF47)-deficient Oncogenic SWI/SNF (BAF) Complex", "year": "2017"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:uWQEDVKXjbEC", "citedby": "0"}, {"bib": {"title": "Abstract B17: Identification of Druggable Targets through Functional Multi-Omics in Renal Medullary Carcinoma", "year": "2017"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:blknAaTinKkC", "citedby": "0"}, {"bib": {"title": "BRD9 defines a novel mammalian SWI/SNF (BAF) complex configuration which supports proliferation in AML", "year": "2017"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:k_IJM867U9cC", "citedby": "0"}, {"bib": {"title": "Loss of function of Arid1a synergizes with MYCN in neuroblastoma pathogenesis", "year": "2017"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:isC4tDSrTZIC", "citedby": "0"}, {"bib": {"title": "Using cancer dependency data to discover tumor suppressive and oncogenic functional modules", "year": "2017"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:TFP_iSt0sucC", "citedby": "0"}, {"bib": {"title": "Targeting NF-KB Activation in Novel Intracranial Models of CNS Lymphoma", "year": "2016"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:-f6ydRqryjwC", "citedby": "0"}, {"bib": {"title": "TMPRSS2-ERG drives global mistargeting of mammalian SWI/SNF (BAF) complexes in prostate cancer", "year": "2016"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:IWHjjKOFINEC", "citedby": "0"}, {"bib": {"title": "Genome-wide mistargeting of oncogenic SWI/SNF (BAF) complexes in SMARCB1 (BAF47)-deficient sarcomas", "year": "2016"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:ZeXyd9-uunAC", "citedby": "0"}, {"bib": {"title": "Abstract IA30: BAF complex structure and function in development and disease", "year": "2016"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:dhFuZR0502QC", "citedby": "0"}, {"bib": {"title": "Methods for identifying and treating cancer patients", "year": "2015"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:YOwf2qJgpHMC", "citedby": "0"}, {"bib": {"title": "Subunit switching of the BAF (mSWI/SNF) complex is governed by an ordered, branched assembly pathway", "year": "2015"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:qUcmZB5y_30C", "citedby": "0"}, {"bib": {"title": "Reversing the oncogenic roles of misdirected chromatin remodeling: Disruption of mSWI/SNF (BAF) complexes by the SS18-SSX fusion in human synovial sarcoma", "year": "2013"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:_xSYboBqXhAC", "citedby": "0"}, {"bib": {"title": "Abstract PR05: Reversing the oncogenic roles of misdirected chromatin remodeling: Disruption of mSWI/SNF (BAF) complexes by the SS18-SSX fusion in human synovial sarcoma", "year": "2013"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:M3ejUd6NZC8C", "citedby": "0"}, {"bib": {"title": "DEVELOPMENT OF NOVEL PATIENT-DERIVED XENOGRAFTS TO DISSECT THE PATHOGENESIS OF CNS LYMPHOMA: 043", "year": "2013"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:TQgYirikUcIC", "citedby": "0"}, {"bib": {"title": "Reversing the oncogenic roles of misdirected chromatin remodeling: Mechanistic insights into the SS18-SSX fusion protein in synovial sarcoma.", "year": "2013"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:aqlVkmm33-oC", "citedby": "0"}, {"bib": {"title": "Reversible disruption of mSWI/SNF-like BAF complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.", "year": "2013"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:_kc_bZDykSQC", "citedby": "0"}, {"bib": {"title": "-Results of an International Randomized Phase III Trial of the", "year": "2013"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:O3NaXMp0MMsC", "citedby": "0"}, {"bib": {"title": "On Cover the", "year": "2013"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:M3NEmzRMIkIC", "citedby": "0"}, {"bib": {"title": "ATP-dependent Chromatin Remodeling in Human Malignancy: Identification and Characterization of Novel Subunits of the MSWI/SNF-like BAF Complex", "year": "2012"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:iH-uZ7U-co4C", "citedby": "0"}, {"bib": {"title": "Dynamic Changes in Macrophage Polarization Correlate with Progression and Response in CNS Lymphoma: Insights Into the Transcriptome of Lymphoma-Associated M2 Macrophages", "year": "2011"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:7PzlFSSx8tAC", "citedby": "0"}, {"bib": {"title": "Genomic and Molecular Properties of Relapsed CNS Lymphoma Using Novel Primary Meningeal Lymphoma Cell Lines and Intracranial Xenografts", "year": "2011"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:0EnyYjriUFMC", "citedby": "0"}, {"bib": {"title": "Interim results of a phase I trial of intraventricular rituximab plus methotrexate in recurrent CNS lymphoma: Macrophage polarization and acquired resistance to therapy.", "year": "2010"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:UebtZRa9Y70C", "citedby": "0"}, {"bib": {"title": "Multivariate analysis of cerebrospinal fluid protein biomarkers in central nervous system lymphoma patients and controls", "year": "2010"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:4TOpqqG69KYC", "citedby": "0"}, {"bib": {"title": "Macrophage polarization and acquired resistance to rituximab in CNS lymphoma", "year": "2010"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:Zph67rFs4hoC", "citedby": "0"}, {"bib": {"title": "Macrophage Polarization and Acquired Resistance to Rituximab in CNS Lymphoma.", "year": "2009"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:YsMSGLbcyi4C", "citedby": "0"}, {"bib": {"title": "CSF Antithrombin III and Disruption of the Blood-Brain Barrier Reply", "year": "2009"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:zYLM7Y9cAGgC", "citedby": "0"}, {"bib": {"title": "Interleukin-4 and Macrophage Polarization in Central Nervous System Lymphoma: 03", "year": "2009"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:HDshCWvjkbEC", "citedby": "0"}, {"bib": {"title": "Development and molecular characterization of an intracranial model of invasive cns lymphoma using bioluminescence imaging", "year": "2008"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:4DMP91E08xMC", "citedby": "0"}, {"bib": {"title": "Protein biomarker identification in the cerebrospinal fluid in patients with central nervous system lymphoma", "year": "2007"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:Se3iqnhoufwC", "citedby": "0"}, {"bib": {"title": "Development of an intracranial model of invasive CNS lymphoma using bioluminescence imaging", "year": "2007"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:WF5omc3nYNoC", "citedby": "0"}, {"bib": {"title": "Complement activation and resistance within the CSF following intraventricular administration of anti-CD20 in the treatment of central nervous system lymphoma", "year": "2007"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:eQOLeE2rZwMC", "citedby": "0"}, {"bib": {"title": "Protein biomarker identification in the cerebrospinal fluid in patients with central nervous system lymphoma", "year": "2007"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:Tyk-4Ss8FVUC", "citedby": "0"}, {"bib": {"title": "Identification of CSF Biomarkers for the Diagnosis of CNS Lymphoma.", "year": "2006"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:Y0pCki6q_DkC", "citedby": "0"}, {"bib": {"title": "Non-Hodgkin\u2019s lymphoma of the brainstem: a case report and discussion.", "year": "2006"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:ufrVoPGSRksC", "citedby": "0"}, {"bib": {"title": "Genitourinary Cancer", "year": "2005"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:L8Ckcad2t8MC", "citedby": "0"}, {"bib": {"title": "User menu", "year": "2004"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:l7t_Zn2s7bgC", "citedby": "0"}, {"bib": {"title": "METHODS FOR MODULATING THE INTERACTION BETWEEN EWS-FLI1 AND BAF COMPLEXES"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:K3LRdlH-MEoC", "citedby": "0"}, {"bib": {"title": "Interrogation of Mammalian Protein Complex Structure, Function, and Membership Using Genome-Scale Fitness Screens"}, "source": "citations", "id_citations": "8_U-eiEAAAAJ:RGFaLdJalmkC", "citedby": "0"}]}